Prevention of colon cancer with the de novo suppressants of iNOS and COX-2 expressions
Prevention of colon cancer with the de novo suppressants of iNOS and COX-2 expressions
批准号:
12556018
负责人:
OHIGASHI Hajime
金额:
$7.68万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Enhanced and sustained expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) are involved in many oncogenic processes, including that in the colon of experimental rodents and human as well. Accordingly, recent laboratory studies have demonstrated the effectiveness of selective inhibitors of iNOS/COX-2 in terms of reduction of the carcinogen-induced development of adenocarcinoma in rats and mice. Of importance, human intervention trials revealed that celecoxib, a cox-2 selective inhibitor, diminished polyp formation of a population of the familial adenomatous polyposis patients. While the cox-2 inhibitors block the catalytic activity, other types of chemicals that suppress or delay the de novo synthesis of iNOS/COX-2 may be considered as a new generation of the anti-iNOS/COX-2 regulators. In the present study, we have identified two food factors, zerumbone (ZER) and nobiletin (NOB), markedly suppressed expression of COX-2 and thereby reducing formation of pr … More ostaglandin E2 in the colonic mucosa of the azoxymethane treated rats. Conversely, these phytochemicals markedly inhibited azoxymethane-induced foramtoin of aberrant crypt foci (ACF) in rat colon. In addition, we observed elevated induction of phase 2 xenobiotic enzyme activities such as glutathione S-transferase and quinone reductase in the colon and liver as compared with the basal diet group. ZER, a sesquiterpene carrying an α,β-unsaturated carbonyl group, a major constituent of Zingiber zerumbet Smith that occurs widely in southea st Asian countries and used as a ingredient of traditional cousins and folk medicine for anti-inflammation as well. On the other hand, NOB, a polymethylated flavonoid, is found in citrus fruits including satsuma mandarin. Our mechanistic studies provided some data that these compounds suppress degradation of the combined lipopolysaccharide and interferon-γ-induced IκBα, a suppressive factor of NF-κB, in RAW murine macrophages. Because NF-κB is one of the major transcription factor for iNOS/COX-2 genes, both ZER and NOB attenuate these gene expressions through suppression of IκB degradation.In conclusion, we have presented an experimental rationale for the used of the iNOS/COX-2 de novo synthesis suppressants, in addition of the cox-2 inhibitors, for preventing and treating large bowel disease such as ulcerative colitis and colorectal cancer. Less
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H. Kohno, S. Yoshitani, Y. Tsukio, A. Murakami, K. Koshimizu, M. Yano, H. Tokuda, H. Nishino, H. Ohigashi, T. Tanaka: "Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats"Life Sci.. 69. 901-913 (200
H. Kohno、S. Yoshitani、Y. Tsukio、A. Murakami、K. Koshimizu、M. Yano、H. Tokuda、H. Nishino、H. Ohigashi、T. Tanaka:“柑橘川陈皮素的饮食可抑制偶氮甲烷诱导的
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.-W.Kim, A.Murakami, M.V.Williams, H.Ohigashi: "Mutagenicity of reactive oxygen and nitrogen species as detected by co-culture of activated inflammatory leukocytes and AS52 cells"Carcinogenesis. 24. 235-241 (2002)
H.-W.Kim、A.Murakami、M.V.Williams、H.Ohigashi:“通过活化炎症白细胞和 AS52 细胞的共培养检测到活性氧和氮的致突变性”致癌作用。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Murakami, D.Takahashi, T.Kinoshita, K.Koshimizu, H.-W.Kim, 他4名: "Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis :
A.Murakami、D.Takahashi、T.Kinoshita、K.Koshimizu、H.-W.Kim 和其他 4 人:“Zerumbone 是一种东南亚姜倍半萜烯,可显着抑制自由基生成、促炎蛋白生成和癌细胞增殖伴随着细胞凋亡:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Murakami, K.Matsumoto, K.Koshimizu, H.Ohigashi: "Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide-and interferon-_-induced IkappaB degradation in RAW264.7 macrophages"Cancer Lett. (印刷中).
A.Murakami、K.Matsumoto、K.Koshimizu、H.Ohigashi:“具有化学预防特性的选定食物因子对 RAW264.7 巨噬细胞中脂多糖和干扰素_诱导的 IkappaB 降解的影响”Cancer Lett。 。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.-W.Kim, A.Murakami, Y.Nakamura, H.Ohigashi: "Screening of edible Japanese plants for suppressing effects on phorbol ester-induced superoxide generation in differentiated HI-60 cells and AS52 cells"Cancer Lett. 176. 7-16 (2002)
H.-W.Kim、A.Murakami、Y.Nakamura、H.Ohigashi:“筛选可食用的日本植物,以抑制分化的 HI-60 细胞和 AS52 细胞中佛波酯诱导的超氧化物生成”Cancer Lett。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Rational design of mixing ratio of food-derived anti-inflammatory factors based on molecular mechanisms.
-
批准号:23658119
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:OHIGASHI Hajime
-
依托单位:
Exploration of anti-inflammatory food factors from plant diets, and chemical classification of such factors based on their action mechanisms
-
批准号:20580139
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:OHIGASHI Hajime
-
依托单位:
Development of new agents that regulate cellular signal transduction
-
批准号:15208012
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$28.45万
-
财政年份:2003
-
负责人:OHIGASHI Hajime
-
依托单位:
Ecochemical study on the medicinal plant use of primates in the wild
-
批准号:08306005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.79万
-
财政年份:1996
-
负责人:OHIGASHI Hajime
-
依托单位:
Bioactive phytochemicals from African savanna woodland
-
批准号:07041139
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.62万
-
财政年份:1995
-
负责人:OHIGASHI Hajime
-
依托单位:
Plants medicinally used by chimpnazees in the wild, and their biologically active constituents
-
批准号:06303012
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$8.38万
-
财政年份:1994
-
负责人:OHIGASHI Hajime
-
依托单位:
Evaluation of dietary plants for superoxide generation (or its inhibition), or scavening activities, and their active constituents
-
批准号:06660156
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1994
-
负责人:OHIGASHI Hajime
-
依托单位:
Antiparasitic Agents from Wild Primate Medicinal Plants
-
批准号:06044122
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.05万
-
财政年份:1994
-
负责人:OHIGASHI Hajime
-
依托单位:
Plants non-nutritiously ingested by wild chimpanzee, and their bioactive constituents
-
批准号:04660143
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1992
-
负责人:OHIGASHI Hajime
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AI驱动的中药抗高血脂作用机制研究:聚焦COX-2靶点的动态与化学蛋白组学解析
-
批准号:JCZRLH202601091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
橙皮苷调控COX-2/PGE2信号通路缓解早期断奶仔猪肠黏膜屏障氧化损伤的分子机制研究
-
批准号:2026JJ81124
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邹立军
-
依托单位:
二氢杨梅素通过GPX4/COX-2途径抑制铁死亡改善顺铂相关性肌少症的机制研究
-
批准号:2026JJ82093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:游利江
-
依托单位:
黄芪外泌体通过下调NF-κB/COX-2/iNOS通路抑制细胞衰老治疗放射性皮肤损伤的机制研究
-
批准号:2026JJ82578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗凌嵘
-
依托单位:
鱼油及其关键代谢酶COX-2/sEH双抑制剂PTUPB对围产期抑郁的作用机制研究
-
批准号:2025JJ40081
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:唐密密
-
依托单位:
海洋真菌多糖AVP141-A重塑精氨酸代谢触发COX-2介导巨噬细胞免疫调节的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:张晓勇
-
依托单位:
益气除痰方促COX-2泛素化修饰调控PEG2/Integrins信号抗肺癌侵袭转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:张恩欣
-
依托单位:
基于HSP70调控COX-2泛素化降解探讨益气除痰方抑制肿瘤相关中性粒细胞抗肺癌转移的机制
-
批准号:2024A02042
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:麦楚填
-
依托单位:
IL-26通过上调COX-2表达调控PMN-MDSC免疫抑制功能促进恶性胸腔积液进展的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:牛怡然
-
依托单位:
Wnt/β-catenin和COX-2的信号串扰在DEHP经微生物-卵巢轴诱发不孕症中的作用机制研究
-
批准号:82360633
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:李娜
-
依托单位: